BIOA
Price
$4.76
Change
+$0.05 (+1.06%)
Updated
Sep 5 closing price
Capitalization
170.65M
59 days until earnings call
NNOMF
Price
$0.74
Change
-$0.03 (-3.90%)
Updated
Sep 5 closing price
Capitalization
83.12M
Interact to see
Advertisement

BIOA vs NNOMF

Header iconBIOA vs NNOMF Comparison
Open Charts BIOA vs NNOMFBanner chart's image
BioAge Labs
Price$4.76
Change+$0.05 (+1.06%)
Volume$159.2K
Capitalization170.65M
Nano One Materials
Price$0.74
Change-$0.03 (-3.90%)
Volume$85.25K
Capitalization83.12M
BIOA vs NNOMF Comparison Chart in %
Loading...
BIOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNOMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIOA vs. NNOMF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOA is a Buy and NNOMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (BIOA: $4.76 vs. NNOMF: $0.74)
Brand notoriety: BIOA and NNOMF are both not notable
BIOA represents the Pharmaceuticals: Generic, while NNOMF is part of the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: BIOA: 123% vs. NNOMF: 148%
Market capitalization -- BIOA: $170.65M vs. NNOMF: $83.12M
BIOA [@Pharmaceuticals: Generic] is valued at $170.65M. NNOMF’s [@Chemicals: Specialty] market capitalization is $83.12M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $220.16B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B. The average market capitalization across the [@Chemicals: Specialty] industry is $9.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOA’s FA Score shows that 0 FA rating(s) are green whileNNOMF’s FA Score has 0 green FA rating(s).

  • BIOA’s FA Score: 0 green, 5 red.
  • NNOMF’s FA Score: 0 green, 5 red.
According to our system of comparison, BIOA is a better buy in the long-term than NNOMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOA’s TA Score shows that 6 TA indicator(s) are bullish while NNOMF’s TA Score has 4 bullish TA indicator(s).

  • BIOA’s TA Score: 6 bullish, 4 bearish.
  • NNOMF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BIOA is a better buy in the short-term than NNOMF.

Price Growth

BIOA (@Pharmaceuticals: Generic) experienced а -3.45% price change this week, while NNOMF (@Chemicals: Specialty) price change was -8.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -1.30%. For the same industry, the average monthly price growth was +4.43%, and the average quarterly price growth was +9.18%.

Reported Earning Dates

BIOA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Chemicals: Specialty (-1.30% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIOA($171M) has a higher market cap than NNOMF($83.1M). NNOMF YTD gains are higher at: 32.533 vs. BIOA (-17.789). NNOMF has higher annual earnings (EBITDA): -8.11M vs. BIOA (-77.68M). BIOA has more cash in the bank: 297M vs. NNOMF (23M). BIOA has less debt than NNOMF: BIOA (8.75M) vs NNOMF (17.9M). BIOA has higher revenues than NNOMF: BIOA (3.86M) vs NNOMF (0).
BIOANNOMFBIOA / NNOMF
Capitalization171M83.1M206%
EBITDA-77.68M-8.11M958%
Gain YTD-17.78932.533-55%
P/E RatioN/AN/A-
Revenue3.86M0-
Total Cash297M23M1,291%
Total Debt8.75M17.9M49%
FUNDAMENTALS RATINGS
BIOA vs NNOMF: Fundamental Ratings
BIOA
NNOMF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
5138
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIOA's Valuation (43) in the Chemicals Specialty industry is in the same range as NNOMF (71) in the null industry. This means that BIOA’s stock grew similarly to NNOMF’s over the last 12 months.

BIOA's Profit vs Risk Rating (100) in the Chemicals Specialty industry is in the same range as NNOMF (100) in the null industry. This means that BIOA’s stock grew similarly to NNOMF’s over the last 12 months.

NNOMF's SMR Rating (97) in the null industry is in the same range as BIOA (99) in the Chemicals Specialty industry. This means that NNOMF’s stock grew similarly to BIOA’s over the last 12 months.

NNOMF's Price Growth Rating (38) in the null industry is in the same range as BIOA (51) in the Chemicals Specialty industry. This means that NNOMF’s stock grew similarly to BIOA’s over the last 12 months.

NNOMF's P/E Growth Rating (100) in the null industry is in the same range as BIOA (100) in the Chemicals Specialty industry. This means that NNOMF’s stock grew similarly to BIOA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOANNOMF
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
71%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
71%
Advances
ODDS (%)
Bullish Trend 11 days ago
69%
Bullish Trend 11 days ago
74%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
BIOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNOMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNBN22.001.00
+4.76%
CNB Bank Shares, Inc.
KYCCF390.007.15
+1.87%
Keyence Corp.
GRKZF23.87N/A
N/A
Greek Organisation of Football Prognostics SA
RHCGF1.43N/A
N/A
Ryman Healthcare Ltd.
SFES0.79-0.04
-5.19%
Safeguard Scientifics, Inc.

BIOA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIOA has been loosely correlated with NNOMF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BIOA jumps, then NNOMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOA
1D Price
Change %
BIOA100%
+1.06%
NNOMF - BIOA
43%
Loosely correlated
-3.11%
CSNVY - BIOA
31%
Poorly correlated
N/A
PPG - BIOA
26%
Poorly correlated
+0.31%
NDEKF - BIOA
25%
Poorly correlated
N/A
AKZOY - BIOA
23%
Poorly correlated
+2.81%
More

NNOMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNOMF has been loosely correlated with BIOA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NNOMF jumps, then BIOA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNOMF
1D Price
Change %
NNOMF100%
-3.11%
BIOA - NNOMF
43%
Loosely correlated
+1.06%
ECVT - NNOMF
28%
Poorly correlated
-0.11%
SXYAY - NNOMF
26%
Poorly correlated
+1.36%
BNTGY - NNOMF
24%
Poorly correlated
+1.00%
BASFY - NNOMF
23%
Poorly correlated
-0.16%
More